J&J consumer sales
This article was originally published in The Tan Sheet
Executive Summary
Fourth quarter sales for McNeil Consumer & Specialty Pharmaceuticals rose 6% to $423 mil. in the U.S. but declined 8% in international markets to $67 mil. For the year, McNeil's domestic revenues increased 6% to $1.54 bil. and international sales dropped 10%, resulting in worldwide sales of $1.8 bil. for 2002, up 3%. Johnson & Johnson highlights strong growth for McNeil Nutritionals' Splenda sweetener and Viactiv calcium chews during the year in a 1Jan. 21 financials release. J&J women's health products recorded 2% worldwide sales gain to $1.25 bil. for the year while skin care revenues advanced 13% to $1.57 bil. on continued strength of Neutrogena, Clean & Clear, Aveeno...
You may also be interested in...
Viactiv
Flavored soft calcium chews in new resealable "to-go" packs will reach retail shelves nationwide in May in time for National Osteoporosis Awareness and Women's Health Months, McNeil Nutritionals announces Feb. 19. Ten-chew packs will carry a suggested retail price of $1.99 and will be available in the original milk chocolate flavor as well strawberry cream - a new flavor that debuted in September. The launch follows strong growth for the brand in 2003 (1"The Tan Sheet" Jan. 27, 2003, In Brief)...
Investors Go Berserk For Viking, Putting It Top Of Q1 Winners
The top 10 biggest share price winners and losers in Q1 from Evaluate show the investor frenzy for obesity drugs continues, while companies with governance doubts see shareholders retreat.
EU Consults On What Constitutes Personal & Commercially Confidential Data In Marketing Applications
Based on their experience with dealing with requests for access to documents over the past 12 years, EU regulators have proposed updating their guideline that provides for a harmonized approach to protecting personal data and business secrets in marketing authorization applications.